160 related articles for article (PubMed ID: 13677885)
1. [Etiology and physiopathology of patients with parkinson's disease].
Ogawa N
Nihon Naika Gakkai Zasshi; 2003 Aug; 92(8):1394-9. PubMed ID: 13677885
[No Abstract] [Full Text] [Related]
2. [Progress in diagnosis and therapy for Parkinson's disease].
Mizuno Y
Nihon Naika Gakkai Zasshi; 2002 Aug; 91(8):2344-8. PubMed ID: 12373846
[No Abstract] [Full Text] [Related]
3. Etiology of Parkinson's disease: Genetics and environment revisited.
Steece-Collier K; Maries E; Kordower JH
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):13972-4. PubMed ID: 12391311
[No Abstract] [Full Text] [Related]
4. Rare genetic mutations shed light on the pathogenesis of Parkinson disease.
Dawson TM; Dawson VL
J Clin Invest; 2003 Jan; 111(2):145-51. PubMed ID: 12531866
[No Abstract] [Full Text] [Related]
5. Alpha-synuclein and Parkinson's disease.
Golbe LI
Adv Neurol; 2003; 91():165-74. PubMed ID: 12442675
[No Abstract] [Full Text] [Related]
6. Dopaminergic drug-induced tics in PARK2-positive Parkinson's disease.
Dafotakis M; Fink GR; Nowak DA
Mov Disord; 2008 Mar; 23(4):628. PubMed ID: 18181204
[No Abstract] [Full Text] [Related]
7. alpha-Synuclein and parkin: coming together of pieces in puzzle of Parkinson's disease.
Burke RE
Lancet; 2001 Nov; 358(9293):1567-8. PubMed ID: 11716878
[No Abstract] [Full Text] [Related]
8. [Genetics of Parkinson's disease].
García de Yébenes J
Neurologia; 2001 Jan; 16(1):1-6. PubMed ID: 11234656
[No Abstract] [Full Text] [Related]
9. [Dopaminergic neuronal death in Parkinson's disease: is accumulation of unfolded proteins a cause or effect?].
Imai Y; Takahashi R
Tanpakushitsu Kakusan Koso; 2004 May; 49(7 Suppl):1113-7. PubMed ID: 15168542
[No Abstract] [Full Text] [Related]
10. Biomedicine. Parkinson's--divergent causes, convergent mechanisms.
Greenamyre JT; Hastings TG
Science; 2004 May; 304(5674):1120-2. PubMed ID: 15155938
[No Abstract] [Full Text] [Related]
11. Parkinson's disease: from causes to mechanisms.
Corti O; Hampe C; Darios F; Ibanez P; Ruberg M; Brice A
C R Biol; 2005 Feb; 328(2):131-42. PubMed ID: 15770999
[TBL] [Abstract][Full Text] [Related]
12. New movement in Parkinson's.
Lozano AM; Kalia SK
Sci Am; 2005 Jul; 293(1):68-75. PubMed ID: 16008304
[No Abstract] [Full Text] [Related]
13. [Parkin, alpha-synuclein and other molecular aspects of Parkinson's disease].
Corti O; Brice A
J Soc Biol; 2002; 196(1):95-10. PubMed ID: 12134640
[TBL] [Abstract][Full Text] [Related]
14. [Genetics and environmental factors of Parkinson disease].
Broussolle E; Thobois S
Rev Neurol (Paris); 2002 Dec; 158 Spec no 1():S11-23. PubMed ID: 12690660
[TBL] [Abstract][Full Text] [Related]
15. The genetics of Parkinson's disease.
Lim KL; Dawson VL; Dawson TM
Curr Neurol Neurosci Rep; 2002 Sep; 2(5):439-46. PubMed ID: 12169225
[TBL] [Abstract][Full Text] [Related]
16. [Studies on pathogenesis of Parkinson's disease].
Mizuno Y
Nihon Naika Gakkai Zasshi; 2005 Feb; 94 Suppl():66-70. PubMed ID: 15796059
[No Abstract] [Full Text] [Related]
17. Genetic and environmental factors in the cause of Parkinson's disease.
Warner TT; Schapira AH
Ann Neurol; 2003; 53 Suppl 3():S16-23; discussion S23-5. PubMed ID: 12666095
[TBL] [Abstract][Full Text] [Related]
18. Parkinson's disease.
Clarke C; Moore A
Clin Evid; 2002 Dec; (8):1370-85. PubMed ID: 12603943
[No Abstract] [Full Text] [Related]
19. Monogenic Parkinsonisms and the genetics of Parkinson's disease.
Bonifati V
Funct Neurol; 2001; 16(1):35-44. PubMed ID: 11396270
[No Abstract] [Full Text] [Related]
20. Dopamine agonists for Parkinson's disease.
Sharma J; MacMahon D; Stewart D
Lancet; 2003 Jan; 361(9351):84; author reply 84. PubMed ID: 12517504
[No Abstract] [Full Text] [Related]
[Next] [New Search]
